RCTS essential in finding evidence-based treatments for COVID-19

Randomized controlled trials are critical in finding an evidence-based treatment for patients with COVID-19, according to a presenter at The Liver Meeting Digital Experience.COVID-19 treatment guidelines from the NIH recommended using remdesivir (Gilead Sciences) and dexamethasone for some patients with COVID-19.In one RCT, patients received 6 mg dexamethasone either orally or intravenously for 10 days either. “In patients receiving oxygen, in particular those receiving invasive mechanical ventilation, there was a benefit with respect to 28-day mortality,” Mark Sulkowski, MD,Read More

Share on facebook
Share on twitter
Share on linkedin